A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Mikhail Fedyanin MD

    Principal Investigator

    Blokhin's Russian Cancer Research Center